Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis.
The role of speed versus working memory in predicting learning new information in multiple sclerosis.
Saturable Leptin Transport Across the BBB Persists in EAE Mice.
Brain disorders where resources are scarce: The unfinished agenda.
Anti-IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in CR-EAE ABH Mice.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Immunogenicity and other problems associated with the use of biopharmaceuticals.
Juvenile myoclonic epilepsy with multiple sclerosis: Is there a dual role for valproate?
A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis.
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial.
[Multiple sclerosis and pregnancy].
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.
[Clinical characteristics of multiple sclerosis in the Tomsk region.]
Factors associated with unemployment among persons with multiple sclerosis.
Aptamers as Promising Molecular Recognition Elements for Diagnostics and Therapeutics in the Central Nervous System.
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study.
Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms.
Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis.
Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.

Pages